Efficacy and Safety of Varenicline Among HIV-infected Patients

PHASE3CompletedINTERVENTIONAL

Enrollment

248

Participants

Timeline

Start Date

October 31, 2009

Primary Completion Date

January 31, 2014

Study Completion Date

July 31, 2014

Conditions

HIV InfectionsTobacco Dependence

Interventions

DRUG

Varenicline

Day 1 to day 3 : 0.5 mg daily ; Day 4 to day 7 : 0.5 mg twice daily ; Day 8 to week 12 : 2 x 0.5 mg twice daily

DRUG

Placebo

Day 1 to day 3 : 1 pill daily ; Day 4 to day 7 : 2 pills daily ; Day 8 to week 12 : 2 pills twice daily

Trial Locations (1)

CHU de Bordeaux, Bordeaux